Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
ACS Omega|September 5, 2022
Self-Assembled Cationic Nanoparticles Combined with Curcumin against Multidrug-Resistant BacteriaJian Bin Zhen, Jiajia Yi, Huan Huan Ding, et al.
Bioorganic Chemistry|November 18, 2021
Dithiocarbamates combined with copper for revitalizing meropenem efficacy against NDM-1-producing Carbapenem-resistant EnterobacteriaceaeCheng Chen, Ke-Wu Yang, Le Zhai, et al.
Bioorganic Chemistry|February 12, 2022
Quinolinyl sulfonamides and sulphonyl esters exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1)Jia-Zhu Chigan, Zhenxin Hu, Lu Liu, et al.
Chemical Biology & Drug Design|December 4, 2021
Hydroxamates as a potent skeleton for the development of metallo-β-lactamase inhibitorsJia-Zhu Chigan, Jia-Qi Li, Huan-Huan Ding, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 4, 2024
Efficacy and safety of ultrasound-guided percutaneous radiofrequency ablation for synovial hyperplasiaQi Xu, Xiao-Hui Xu, Ze-Zheng Liu, et al.
Bioorganic & Medicinal Chemistry|April 16, 2021
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamasesJia-Qi Li, Han Gao, Le Zhai, et al.
International Journal of Cancer|May 20, 2020
Oxaliplatin-induced neuropathic pain involves HOXA6 via a TET1-dependent demethylation of the SOX10 promoterJie Deng, Huan-Huan Ding, Jia-Li Long, et al.
Bioorganic Chemistry|December 31, 2020
Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitorsJia-Qi Li, Le-Yun Sun, Zhihui Jiang, et al.
Texas Heart Institute Journal|July 16, 2015
Is autologous or heterologous pericardium better for valvuloplasty? A comparative study of calcification propensityWen-Jian Jiang, Yong-Chao Cui, Jin-Hua Li, et al.
Bioorganic Chemistry|April 24, 2022
Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antiviralsYin-Sui Xu, Jia-Zhu Chigan, Jia-Qi Li, et al.
Pageof 3